Precursor Cell Lymphoblastic Leukemia-Lymphoma
"Precursor Cell Lymphoblastic Leukemia-Lymphoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.
MeSH Number(s)
C04.557.337.428.600
C15.604.515.560.600
C20.683.515.528.600
Concept/Terms
Precursor Cell Lymphoblastic Leukemia-Lymphoma- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Precursor Cell Lymphoblastic Leukemia Lymphoma
- Leukemia, Lymphoblastic
- Leukemia, Lymphoblastic, Acute
- Leukemia, Lymphocytic, Acute
- Lymphoma, Lymphoblastic
- Lymphoblastic Leukemia
- Lymphoblastic Leukemia, Acute
- Acute Lymphoblastic Leukemia
- Leukemia, Acute Lymphoblastic
- Lymphoblastic Lymphoma
- Lymphomas, Lymphoblastic
- Lymphocytic Leukemia, Acute
- Acute Lymphocytic Leukemia
- Leukemia, Acute Lymphocytic
- Acute Lymphoid Leukemia
- Leukemia, Acute Lymphoid
- Lymphoid Leukemia, Acute
- Leukemia, Lymphoid, Acute
Leukemia, Lymphocytic, Acute, L1- Leukemia, Lymphocytic, Acute, L1
- Lymphocytic Leukemia, L1
- L1 Lymphocytic Leukemia
- Leukemia, L1 Lymphocytic
- Lymphoblastic Leukemia, Acute, Childhood
- Lymphoblastic Leukemia, Acute, L1
- ALL, Childhood
- Childhood ALL
- Leukemia, Lymphoblastic, Acute, L1
Leukemia, Lymphocytic, Acute, L2- Leukemia, Lymphocytic, Acute, L2
- Lymphocytic Leukemia, L2
- L2 Lymphocytic Leukemia
- Leukemia, L2 Lymphocytic
- Lymphoblastic Leukemia, Acute, Adult
- Lymphoblastic Leukemia, Acute, L2
- Leukemia, Lymphoblastic, Acute, L2
- Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
Below are MeSH descriptors whose meaning is more general than "Precursor Cell Lymphoblastic Leukemia-Lymphoma".
Below are MeSH descriptors whose meaning is more specific than "Precursor Cell Lymphoblastic Leukemia-Lymphoma".
This graph shows the total number of publications written about "Precursor Cell Lymphoblastic Leukemia-Lymphoma" by people in Harvard Catalyst Profiles by year, and whether "Precursor Cell Lymphoblastic Leukemia-Lymphoma" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 10 | 6 | 16 |
| 1992 | 11 | 4 | 15 |
| 1993 | 8 | 5 | 13 |
| 1994 | 12 | 1 | 13 |
| 1995 | 13 | 5 | 18 |
| 1996 | 12 | 2 | 14 |
| 1997 | 15 | 3 | 18 |
| 1998 | 12 | 2 | 14 |
| 1999 | 7 | 1 | 8 |
| 2000 | 12 | 2 | 14 |
| 2001 | 13 | 3 | 16 |
| 2002 | 11 | 4 | 15 |
| 2003 | 14 | 3 | 17 |
| 2004 | 16 | 2 | 18 |
| 2005 | 19 | 4 | 23 |
| 2006 | 17 | 6 | 23 |
| 2007 | 19 | 4 | 23 |
| 2008 | 12 | 11 | 23 |
| 2009 | 18 | 3 | 21 |
| 2010 | 20 | 5 | 25 |
| 2011 | 21 | 5 | 26 |
| 2012 | 19 | 2 | 21 |
| 2013 | 20 | 2 | 22 |
| 2014 | 25 | 4 | 29 |
| 2015 | 25 | 2 | 27 |
| 2016 | 36 | 5 | 41 |
| 2017 | 27 | 5 | 32 |
| 2018 | 31 | 0 | 31 |
| 2019 | 33 | 3 | 36 |
| 2020 | 29 | 1 | 30 |
| 2021 | 6 | 0 | 6 |
Below are the most recent publications written about "Precursor Cell Lymphoblastic Leukemia-Lymphoma" by people in Profiles.
-
Caloric and nutrient restriction to augment chemotherapy efficacy for acute lymphoblastic leukemia: the IDEAL trial. Blood Adv. 2021 04 13; 5(7):1853-1861.
-
Participation in the College of American Pathologists Laboratory Accreditation Program Decreases Variability in B-Lymphoblastic Leukemia and Plasma Cell Myeloma Flow Cytometric Minimal Residual Disease Testing: A Follow-up Survey. Arch Pathol Lab Med. 2021 03 01; 145(3):336-342.
-
Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies. BMC Cancer. 2021 Feb 25; 21(1):198.
-
Genetic ancestry and skeletal toxicities among childhood acute lymphoblastic leukemia patients in the DFCI 05-001 cohort. Blood Adv. 2021 01 26; 5(2):451-458.
-
Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia. Blood Adv. 2021 01 26; 5(2):504-512.
-
Molecular basis of ETV6-mediated predisposition to childhood acute lymphoblastic leukemia. Blood. 2021 01 21; 137(3):364-373.
-
Targeting the Ras pathway in pediatric hematologic malignancies. Curr Opin Pediatr. 2021 02 01; 33(1):49-58.
-
Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies. Lancet. 2020 12 12; 396(10266):1885-1894.
-
Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma. Blood Adv. 2020 11 10; 4(21):5414-5424.
-
Anti-CD19 chimeric antigen receptor T-cell therapy in acute lymphocytic leukaemia: a systematic review and meta-analysis. Lancet Haematol. 2020 Nov; 7(11):e816-e826.